According to several systematic reviews and meta-analysis studies, it has been found that CKI can not only improve the clinical efficacy in gastric cancer patients but also mitigate the adverse effects of radiotherapy and chemotherapy (Zhang et al., 2017, 2018; Huang and Wei, 2019). This evidence concerns the gene CHKA and gastric cancer.